Dr. Emma Uchida is a pharmacist who is specialized in Oncology in Lexington, Kentucky. Patients can reach her at 800 Rose St, Lexington or contact her on 859-257-4488. Active license number of Dr. Emma Uchida is 020658 for Oncology in Kentucky. Dr. Emma Uchida is a licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.
Complete Profile:
Dr. Emma Uchida speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Dr. Emma Uchida
Specialization:
Oncology
Credentials:
PHARMD
Gender:
Female
Location:
800 Rose St, Lexington, Kentucky, 40536-1200
Phone:
859-257-4488
Fax:
859-257-6002
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Emma Uchida are as mentioned below.
NPI Number:
1851000418
NPI Enumeration Date:
22 Nov, 2022
NPI Last Update On:
30 Jul, 2024
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Emma Uchida are as mentioned below.
Specialization
License Number
State
Status
Oncology
020658
Kentucky
Primary
Oncology
RP0012622
West Virginia
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3405 Oakbrook Dr, Lexington, Kentucky
Zip:
40515-1317
Phone Number:
724-470-6333
Fax Number:
--
Patients can reach Dr. Emma Uchida at 800 Rose St, Lexington, Kentucky or can call on phone at 859-257-4488.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.